Federation Des Caisses Desjardins Du Quebec Applied Genetic Technologies Corp Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 30, 2024
SELL
$1.87 - $2.91 $3,048 - $4,743
-1,630 Closed
0 $0
Q2 2021

Aug 30, 2024
BUY
$3.62 - $5.23 $5,900 - $8,524
1,630 New
1,630 $6.37 Million
Q4 2020

Aug 30, 2024
BUY
$3.99 - $5.7 $6,503 - $9,291
1,630 New
1,630 $6.67 Million
Q2 2020

Aug 30, 2024
SELL
$3.0 - $6.9 $78,891 - $181,449
-26,297 Closed
0 $0
Q4 2018

Aug 30, 2024
BUY
$2.28 - $7.15 $59,957 - $188,023
26,297 New
26,297 $65.6 Million
Q1 2017

Aug 30, 2024
BUY
N/A
26,297
26,297 $181 Million

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email